Epinephrine intranasal spray (ARS Pharmaceuticals)

肾上腺素鼻喷雾剂（ARS Pharmaceuticals）

Report date: 2026/04/16 20:00:17

Base Information

Drug NameEpinephrine intranasal spray (ARS Pharmaceuticals)
Drug Alias NameAdrenaline nasal sprayNeffyEUR neffyEURneffyARS-1 +[6] 
ClassificationSmall molecules
Mechanisms of ActionBeta adrenergic receptors agonistsAlpha adrenergic receptor agonists
TargetsBeta adrenergic receptorsAlpha adrenergic receptor
Therapy Area/IndicationsAnaphylaxisChronic UrticariaUrticaria +[5] 
Global Approved IndicationsAnaphylaxis
Approved Indications in ChinaAnaphylaxis
Original Approved Country/TerritoryEU
Original Approved Date2024/06/28
Country/TerritoryCanadaUnited StatesAustralia +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesARS Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesARS Pharmaceuticals Operations IncCSL SeqirusARS Pharmaceuticals Inc +[5] 
Inactive CompaniesPediatrix Therapeutics
Active IndicationsAnaphylaxisChronic UrticariaUrticaria +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A